BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Radico Khaitan Ltd.’s Q2 FY21 was healthy on the operating front in backdrop of Covid-19, discretionary category, lack of on-trade sales and steep rise in taxes.
The company’s volume grew by 4.6% YoY (down 42% in Q1 FY21). The company’s revenue/Ebitda/adjusted profit after tax grew by 10.5/24/36% YoY.
Over the last three years, the company experienced robust volume growth, price increases, premiumisation, raw material tailwinds, and thus de-leveraging.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR